Figure 8.Pattern diagram showing that ZnC slows the progression of CRC by inhibiting the proliferation, invasion and migration and up-regulates PD-L1 expression via inhibiting miR-570. The combination of ZnC and anti-PD1 therapy is beneficial to synergically increase efficacy of anti-tumor in CRC therapy.
